About the journal
The Oncologist is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,668 USD. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Oxford University Press
- ISSN
- 1083-7159 · 1549-490X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,668 USD
- Articles in DOAJ
- 0
- Declared review time
- 19 weeks
- Declared peer-review model
- peer_review
- Official website
- https://academic.oup.com/oncolo
Index listings
- DOAJ · 2022-06-15
- MEDLINE · 1999-01-01
- PUBMED · 2016-03-14
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,668 USD
- Declared review time (DOAJ)
- 19 weeks
- Actual review time (measured)
- 112 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
19weeks
Works in OpenAlex
7473
Last recorded publication year
2026
h-index
227
i10-index
4287
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-03
- Added to DOAJ
- 2022-06-15
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 72%
- ORCID iDs in current deposits
- 70%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9607837
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
Show all subjects (50)
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- HER2/EGFR in Cancer Research
- Cancer Genomics and Diagnostics
- HER2/EGFR in Cancer Research
- Cancer Genomics and Diagnostics
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Renal cell carcinoma treatment
- Cancer survivorship and care
- Cancer survivorship and care
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Renal cell carcinoma treatment
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Hepatocellular Carcinoma Treatment and Prognosis
- Palliative Care and End-of-Life Issues
- Palliative Care and End-of-Life Issues
- Hepatocellular Carcinoma Treatment and Prognosis
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Prostate Cancer Treatment and Research
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Prostate Cancer Treatment and Research
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- BRCA gene mutations in cancer
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- BRCA gene mutations in cancer
Keywords (DOAJ)
- cancer
- oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ